We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Electron Canon Purifies Indoor Environments

By HospiMedica International staff writers
Posted on 04 May 2021
A novel virus deactivation system uses an extremely high-intensity discharge of electrons to actively impede air and surface transmission of the Corona family of viruses.

The Shreis Scalene Therapeutics (SSTx; Gaithersburg, MD, USA) scalene hypercharge corona canon (Shycocan) uses proprietary photon-mediated electron emitters (PMEEs) to discharge trillions of electrons every second. The intense kinetic energy impedes the negative-charge seeking mechanism of the SARS-CoV-2 spike protein, actively disarming air and surface transmission. Shycocan does not use any chemicals, and does not produce ozone, reactive oxygen species (ROS), oxides of nitrogen, or other harmful compounds.

Image: The Shycocan device emits an electron stream to disrupt virus transmission (Photo courtesy of SSTx)
Image: The Shycocan device emits an electron stream to disrupt virus transmission (Photo courtesy of SSTx)

The technology is based on a super alloy, scalene, that release the hypercharged electrons. The plug and play device requires no setup, except for mounting on side wall, pedestal, or table-top, and access to a power outlet. Once turned on, Shycocan begins working instantaneously. The device can be deployed in all environments, and does not interfere with other electronic devices such as air conditioning or cellular communications. It is also being studied for use in farms to prevent the transmission of the G4-EA-H1N1 virus, described as being highly adapted to infect humans.

“No ultraviolet light, filter-systems, hazardous ozone, or other harmful chemical emission occurs with the Shycocan,” said Professor Meena Augustus PhD, founder, president, CEO, and CSO of SSTx. “A salient feature of this technology, that has also been biologically validated, is that while viruses are targeted, beneficial bacteria, fungi or other micro-organisms, human and mammalian epithelial cells are not, making it eco-, people, and pet friendly.”

Related Links:
Shreis Scalene Therapeutics


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Fetal and Maternal Monitor
F9 Series
New
Anterior Cervical Plate System
XTEND

Latest Critical Care News

Ablation Treatment Better Than Medication for Heart Attack Survivors

Cranial Accelerometry Headset Enables Timely and Accurate Prehospital Detection of LVO Strokes

Ingestible Capsule Pump Drugs Directly into Walls of GI Tract